Actinium Pharmaceuticals, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2010 | $7.8K | $7.8K | — | $21.2K |
| FY2011 | $-517.6K | $-517.6K | — | $2.2M |
| FY2012 | $-5.2M | $-5.2M | $2.4K | $2.2M |
| FY2013 | $-6.3M | $-6.3M | $16.6K | $657.8K |
| FY2014 | $-14.3M | $-14.5M | $151.7K | $6.3M |
| FY2015 | $-18.5M | $-18.6M | $47.8K | $7.1M |
| FY2016 | $-20.8M | $-20.8M | $60.0K | $4.3M |
| FY2017 | $-21.6M | $-21.6M | $24.7K | $3.5M |
| FY2018 | $-20.6M | $-20.7M | $96.1K | $1.8M |
| FY2019 | $-21.5M | $-21.5M | $64.0K | $1.3M |
| FY2020 | $-21.6M | $-21.9M | $253.0K | $1.3M |
| FY2021 | $-20.9M | $-21.0M | $133.0K | $1.7M |
| FY2022 | $8.6M | $8.3M | $366.0K | $2.8M |
| FY2023 | $-47.3M | $-47.5M | $153.0K | $3.8M |
| FY2024 | $-33.1M | $-33.1M | $11.0K | $5.3M |
| FY2025 | $-24.6M | $-24.7M | $104.0K | $9.2M |